We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Zurn Elkay Water Solutions
ZWS
$8.82B
| $4.79M | 0.01% |
106,926
+4,962
| +5% | +$237K |
|
|
CGAU
827
Centerra Gold
CGAU
$3.55B
| $4.78M | 0.01% |
268,723
-79,104
| -23% | -$1.41M |
|
828
CenterPoint Energy
CNP
$27.4B
| $4.75M | 0.01% |
110,155
-1,204
| -1% | -$49.7K |
|
829
MACOM Technology Solutions
MTSI
$20.9B
| $4.73M | 0.01% |
21,316
-420
| -2% | -$93.8K |
|
830
Cheesecake Factory
CAKE
$5.26B
| $4.72M | 0.01% |
86,227
-744
| -0.9% | -$44.3K |
|
831
Open Text
OTEX
$6.41B
| $4.72M | 0.01% |
211,860
+29,646
| +16% | +$770K |
|
|
AUTL
832
Autolus Therapeutics
AUTL
$519M
| $4.64M | 0.01% |
3,361,156
| – | – |
|
833
UDR
UDR
$12.4B
| $4.62M | 0.01% |
136,697
-10,103
| -7% | -$371K |
|
834
Best Buy
BBY
$18.2B
| $4.62M | 0.01% |
71,914
-24,784
| -26% | -$1.63M |
|
835
Adeia
ADEA
$3.44B
| $4.6M | 0.01% |
191,550
-3,785
| -2% | -$76.7K |
|
836
TransDigm Group
TDG
$71.3B
| $4.6M | 0.01% |
3,965
-390
| -9% | -$511K |
|
|
GAP
837
The Gap Inc
GAP
$7.42B
| $4.59M | 0.01% |
189,743
+112,805
| +147% | +$2.98M |
|
838
Invesco NASDAQ 100 ETF
QQQM
$102B
| $4.59M | 0.01% |
19,301
| – | – |
|
839
Apogee Therapeutics
APGE
$10.1B
| $4.58M | 0.01% |
54,437
+14,591
| +37% | +$1.06M |
|
|
INGM
840
Ingram Micro Holding
INGM
$6.74B
| $4.57M | 0.01% |
+195,894
| New | +$4.26M |
|
841
Carvana
CVNA
$74.8B
| $4.56M | 0.01% |
72,575
-8,510
| -10% | -$631K |
|
|
HSAI
842
Hesai Group
HSAI
$2.88B
| $4.54M | 0.01% |
246,630
+91,398
| +59% | +$2.3M |
|
843
EQT Corp
EQT
$33B
| $4.54M | 0.01% |
71,400
-12,020
| -14% | -$704K |
|
844
Darling Ingredients
DAR
$9.56B
| $4.53M | 0.01% |
73,305
-5,817
| -7% | -$286K |
|
845
Imperial Oil
IMO
$61.6B
| $4.52M | 0.01% |
34,533
+22,220
| +180% | +$2.49M |
|
846
Bunge Global
BG
$20.5B
| $4.41M | 0.01% |
34,699
+30,286
| +686% | +$3.52M |
|
847
Qualys
QLYS
$5.67B
| $4.41M | 0.01% |
50,238
+83
| +0.2% | +$9.2K |
|
848
NETSCOUT
NTCT
$3.07B
| $4.38M | 0.01% |
137,694
-4,096
| -3% | -$119K |
|
849
PAR Technology
PAR
$719M
| $4.35M | 0.01% |
326,248
-34,133
| -9% | -$802K |
|
850
Trinity Industries
TRN
$2.55B
| $4.33M | 0.01% |
134,579
-3,779
| -3% | -$116K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.